论文部分内容阅读
探讨ＡｇＮＯＲ技术及ＣＴ扫描联合诊断肺癌纵隔淋巴结转移的可行性。应用ＡｇＮＯＲ技术和ＣＴ扫描对３８例肺癌纵隔淋巴结转移情况进行分析。伴淋巴结转移肺癌的ＡｇＮＯＲ／核均数显著高于无淋巴结转移肺癌（Ｐ＜０．０５）。ＣＴ扫描淋巴结短径≥８ｍｍ的１０例肺癌中淋巴结转移７例，此７例肺癌细胞的ＡｇＮＯＲ／核均数为８．９７±０．７２，且ＡｇＮＯＲ颗粒均表现为聚集型。提示以肺癌细胞核内ＡｇＮＯＲ颗粒为聚集型，Ａｇ－ＮＯＲ／核均数≥８，ＣＴ扫描淋巴结短径≥８ｍｍ作为标准诊断肺癌纵隔淋巴结转移有较高的特异性及敏感性。ＡｇＮＯＲ技术及ＣＴ扫描联合诊断肺癌纵隔淋巴结转移有较好的临床应用前景
To explore the feasibility of the combination of AgNOR technology and CT scan in the diagnosis of mediastinal lymph node metastasis of lung cancer. The AgNOR technique and CT scan were used to analyze the metastases of 38 cases of mediastinal lymph nodes. AgNOR/nucleus mean number of lung cancer with lymph node metastasis was significantly higher than that without lymph node metastasis (P<0.05). The lymph node metastasis of lung cancer in 10 cases of lung cancer with a short diameter of ≥8mm in the CT scan was 7 cases. The AgNOR/nucleus mean number of the 7 lung cancer cells was 8.97±0.72, and AgNOR granules were aggregated. The results showed that AgNOR particles in the nucleus of lung cancer were aggregated, Ag-NOR/nucleus average ≥8, CT scan lymph node short diameter ≥8mm as a standard for the diagnosis of mediastinal lymph node metastasis of lung cancer with high specificity and sensitivity. AgNOR Technique and CT Scan in Diagnosis of Mediastinal Lymph Node Metastasis of Lung Cancer Have Better Clinical Application Prospects